Literature DB >> 7735400

Pediatric human immunodeficiency virus infection. Recent evidence on the utilization and costs of health services.

D C Hsia1, J A Fleishman, J A East, F J Hellinger.   

Abstract

OBJECTIVE: To measure the utilization and costs of pediatric human immunodeficiency virus (HIV)-related health care services.
DESIGN: Cohort survey.
SETTING: Eight outpatient departments serving large numbers of HIV-infected children in five standard metropolitan areas with high prevalence of HIV-infected children. PATIENTS: One hundred forty-one HIV-seropositive children older than 15 months of age or children whose clinical conditions meet the definition of acquired immunodeficiency syndrome (AIDS) at any age who visited the selected providers during the second quarter of 1991.
INTERVENTIONS: None. MAIN OUTCOME MEASURES: Quarterly interview survey (via adult proxies) of health care services utilization during each preceding 3-month period, repeated six times between March 1991 and August 1992. Charge data were abstracted from inpatient, outpatient, home health care, and pharmacy bills.
RESULTS: Children with AIDS averaged 1.4 hospitalizations, 16 inpatient days, two emergency department visits, 18 ambulatory care visits, 15 professional home health care visits, and one dental visit per year, generating an estimated $37,928 in annual charges. The HIV-infected children used fewer services, with annual charges of $9382.
CONCLUSIONS: We found lower utilization than reported in prior research on pediatric HIV and similar unit costs after inflation adjustment. Increasing experience in clinical management and expanded ambulatory care may have contributed to reductions in inpatient services utilization and total costs since the mid-1980s.

Entities:  

Mesh:

Year:  1995        PMID: 7735400     DOI: 10.1001/archpedi.1995.02170180019003

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  9 in total

1.  The communicable disease impact of eliminating publicly funded prenatal care for undocumented immigrants.

Authors:  H Kuiper; G A Richwald; H Rotblatt; S Asch
Journal:  Matern Child Health J       Date:  1999-03

2.  Access to prenatal HIV testing.

Authors:  R S Remis; D M Patrick
Journal:  CMAJ       Date:  1998-06-02       Impact factor: 8.262

3.  Costs and benefits of screening pregnant women for HIV.

Authors:  H Bueckert
Journal:  CMAJ       Date:  1996-11-15       Impact factor: 8.262

4.  Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre.

Authors:  E J Beck; S Mandalia; R Griffith; J Beecham; M D Walters; M Boulton; D L Miller
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

Review 5.  The cost of HIV treatment and care. A global review.

Authors:  E J Beck; A H Miners; K Tolley
Journal:  Pharmacoeconomics       Date:  2001-01       Impact factor: 4.981

6.  Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.

Authors:  R D Gorsky; P G Farnham; W L Straus; B Caldwell; D R Holtgrave; R J Simonds; M F Rogers; M E Guinan
Journal:  Public Health Rep       Date:  1996 Jul-Aug       Impact factor: 2.792

Review 7.  Economic issues in the prevention of vertical transmission of HIV.

Authors:  A E Ades; J Ratcliffe; D M Gibb; M J Sculpher
Journal:  Pharmacoeconomics       Date:  2000-07       Impact factor: 4.981

8.  The effect of prophylaxis on pediatric HIV costs.

Authors:  Leslie S Wilson; Lori Hensic; Carly J Paoli; Rituparna Basu; Maria Christenson; Judith T Moskowitz; Diane Wara
Journal:  AIDS Care       Date:  2011-07-25

9.  Routine prenatal screening for HIV in a low-prevalence setting.

Authors:  D M Patrick; D M Money; J Forbes; S R Dobson; M L Rekart; D A Cook; P J Middleton; D R Burdge
Journal:  CMAJ       Date:  1998-10-20       Impact factor: 8.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.